Prevention of Age-Related Macular Degeneration
dc.creator | L. K, Gazizova | |
dc.creator | B. O, Ermatova | |
dc.date | 2023-06-09 | |
dc.date.accessioned | 2023-08-21T09:05:02Z | |
dc.date.available | 2023-08-21T09:05:02Z | |
dc.description | Age-related macular degeneration (AMD) is a common eye disease that leads to a significant decrease in vision and threatens with disability. According to official data from the WHO Center for the Prevention of Avoidable Blindness, the prevalence of this pathology is 300 per 100,000 people. The disease occurs in 40% of cases among people over 40 years old, in 58-100% - over 60 years old. | en-US |
dc.format | application/pdf | |
dc.identifier | https://univerpubl.com/index.php/scholastic/article/view/1973 | |
dc.identifier.uri | http://dspace.umsida.ac.id/handle/123456789/22078 | |
dc.language | eng | |
dc.publisher | Univer Publishing | en-US |
dc.relation | https://univerpubl.com/index.php/scholastic/article/view/1973/1721 | |
dc.source | Scholastic: Journal of Natural and Medical Education; Vol. 2 No. 6 (2023): Scholastic: Journal of Natural and Medical Education; 51-55 | en-US |
dc.subject | age-related macular degeneration | en-US |
dc.subject | vitamin D | en-US |
dc.subject | drusen | en-US |
dc.subject | angiogenesis inhibitors | en-US |
dc.title | Prevention of Age-Related Macular Degeneration | en-US |
dc.type | info:eu-repo/semantics/article | |
dc.type | info:eu-repo/semantics/publishedVersion | |
dc.type | Peer-reviewed Article | en-US |